Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | |||
| marinesco-sjogren_syndrome [2026/04/29 18:59] – Scott Larson | marinesco-sjogren_syndrome [2026/07/28 19:27] (current) – Scott Larson | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== Marinesco-Sjögren Syndrome ====== | ====== Marinesco-Sjögren Syndrome ====== | ||
| - | FIXME | + | |
| - | [[http:// | + | Rare autosomal recessive multisystem disorder characterized by a classic tetrad: |
| + | - Cerebellar ataxia | ||
| + | - Early-onset cataracts | ||
| + | - Intellectual disability | ||
| + | - Progressive myopathy. | ||
| + | |||
| + | ====Main Features==== | ||
| + | |||
| + | * **Cerebellar ataxia** — present in >90% of patients, with cerebellar atrophy seen on MRI in 100% | ||
| + | * **Cataracts** — present in 95–100%; mean onset ~3.5 years; typically requires lens extraction in the first decade of life | ||
| + | * **Intellectual disability** — present in >90%; ranges from mild to severe, though normal intelligence has been reported | ||
| + | * **Myopathy** — myopathic changes on EMG or muscle biopsy in >90%; muscle weakness, hypotonia, and atrophy are common* | ||
| + | * **Hypotonia** — present in 95–100% | ||
| + | |||
| + | ====Eye Findings==== | ||
| + | |||
| + | * **Cataracts** — the hallmark ocular feature (95–100%); | ||
| + | * **Strabismus** — present in 60–80% of affected individuals | ||
| + | * **Nystagmus** — observed in ~50%, likely related to cerebellar dysfunction | ||
| + | * **Optic atrophy** — rare; reported in a review of 75 patients | ||
| + | * **Glaucoma** — rare | ||
| + | * **Microphthalmia** — rare | ||
| + | * **Retinal degeneration** — rare | ||
| + | * **Iris coloboma** — reported as a novel finding in some patients | ||
| + | |||
| + | ====Other Findings==== | ||
| + | |||
| + | * **Hypergonadotropic hypogonadism** — 50–70%; delayed or absent puberty; no associated congenital genital anomalies described | ||
| + | * **Short stature** — 50–70%; microcephaly occasionally reported | ||
| + | * **Skeletal abnormalities** — ~50%; includes scoliosis, shortened metacarpals/ | ||
| + | * **Dysarthria** — reported in ~45% of patients | ||
| + | * **Pyramidal tract signs** — modestly constant feature | ||
| + | * **Dental abnormalities** — reported in some patients | ||
| + | * **Life span** — appears to be near normal despite significant disability | ||
| + | |||
| + | ====Etiology==== | ||
| + | |||
| + | * **Gene:** SIL1 (chromosome 5q31) | ||
| + | * **Protein: | ||
| + | * **Function: | ||
| + | * **Pathophysiology: | ||
| + | * **Inheritance: | ||
| + | * **Genetic heterogeneity: | ||
| + | * **Founder effect:** In Japan, the SIL1 c.936dupG (p.Leu313fs) mutation was found on 43/48 chromosomes tested, with haplotype analysis suggesting a founder effect | ||
| + | |||
| + | ====References==== | ||
| + | |||
| + | - [[https:// | ||
| + | - [[https:// | ||
| + | - [[https:// | ||
| + | - [[https:// | ||
| + | - [[https:// | ||
| + | - [[https:// | ||
| + | - [[https:// | ||
| + | - [[https:// | ||
| + | - [[http:// | ||
| {{tag> | {{tag> | ||